YM-430

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameYM-430

Drug Alias NameYM-154301YM-430YM-15430

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated calcium channel blockersBeta-1 adrenergic receptor antagonists

TargetsVoltage-gated calcium channelBeta-1 adrenergic receptor

Therapy Area/IndicationsHypertensionAngina Pectoris

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHypertensionAngina Pectoris

ATC CodeN/A